黄类补充剂是否可以缓解非酒精性脂肪性肝病? 随机对照试验的系统审查和元分析
1Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, School of Food and Health, Beijing Technology and Business University, Beijing, 100048, China.
Molecular nutrition & food research
|October 25, 2023
概括
黄类补充剂对管理非酒精性脂肪性肝病 (NAFLD) 是有前途的. 本综述表明,黄类药物改善了NAFLD成年人的肝功能,脂质样本和炎症.
科学领域:
- 营养科学 营养科学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 更高的黄类药物摄入量与非酒精性脂肪性肝病 (NAFLD) 的风险降低有关.
- 关于黄类补充剂对NAFLD的具体影响存在重大差异.
- 由于存在知识差距,需要对现有的随机临床试验 (RCT) 进行全面审查.
研究的目的:
- 系统地审查评估黄类补充剂对NAFLD影响的RCT.
- 批判性地评估黄类药物对NAFLD成人的肝功能,脂质样本,炎症和胰岛素耐药性的影响.
主要方法:
- 从创立到2023年5月,对四个数据库进行了系统搜索.
- 在最终的元分析中包括了12个RCT.
- 统计分析包括标准化平均差异 (SMD) 和p值的平均差异 (MD).
主要成果:
- 黄类药物显著降低了氨酸转移酶 (ALT),阿斯巴酸转移酶 (AST) 和胺转移酶 (GGT).
- 补充改善了脂质特征,包括甘油三 (TG),LDL胆固醇 (LDL-C) 和总胆固醇 (TC).
- 黄类药物通过降低TNF-α和NF-κB水平显示出抗炎作用.
结论:
- 黄类补充剂通过改善肝功能,脂质配置和炎症来有效地缓解NAFLD.
- 黄类药物代表了一种有前途的治疗策略,用于管理NAFLD及其并发症.
- 进一步的研究可能会巩固黄素作为NAFLD治疗方案的关键组成部分.
相关概念视频
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
676
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
676
01:28Overview of Fatty Acid Metabolism
30.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.7K
01:26Diseases of the Liver and Gallbladder
585
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
585
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
117
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
117